Oppenhoff Advises Resonant Clinical Solutions on the Acquisition of Labfish

Hamburg – Oppen­hoff advi­sed Reso­nant Clini­cal Solu­ti­ons, a port­fo­lio company of Audax Private Equity, on its acqui­si­tion of labfish rental solu­ti­ons GmbH and its affi­lia­ted compa­nies (“Labfish”) in the United States and the United King­dom. With this acqui­si­tion, Reso­nant is further expan­ding its presence in the Euro­pean Equip­ment & Ancil­la­ries (E&A) market and broa­de­ning its range of services for complex clini­cal trials. 

Reso­nant is a global provi­der of solu­ti­ons for life scien­ces compa­nies across the clini­cal supply chain and the entire life cycle of biolo­gi­cal samples. Among other things, the company offers services for the storage and manage­ment of biolo­gi­cal samples, as well as the provi­sion of kits, devices, and supple­men­tary mate­ri­als for clini­cal trials. Reso­nant employs more than 850 people in the U.S. and Europe and has supported over 2,500 clini­cal trials to date. 

Labfish, head­quar­te­red in Hamburg, was foun­ded in 2014 and supplies labo­ra­tory and clini­cal equip­ment. In addi­tion, the company offers cali­bra­tion, import, and export services, as well as logi­stics services for clini­cal trials. Labfish supplies trial sites in more than 70 count­ries and opera­tes one of the largest company-owned cali­bra­tion faci­li­ties for clini­cal trials in Europe. 

Audax Private Equity, head­quar­te­red in Boston with addi­tio­nal offices in San Fran­cisco, New York, London, and Hong Kong, is a leading private equity firm focu­sed on inves­t­ing in mid-market compa­nies in North America.
https://audaxprivateequity.com/

Consul­tant at Reso­nant Clini­cal Solu­ti­ons: Oppenhoff

Led by Dr. Markus Rasner, Moritz Schmitz, Laurenz Kiefer (all Private Equity), Dr. Gunnar Knorr (Tax), Dr. Wolf­gang Kotzur (Finance), Anja Dombrow­sky and Lisa Strieg­ler (both Employ­ment Law), Maxi­mi­lian Broich (Compli­ance), Valen­tino Halim and Melissa Irtel (both IT/Data Protec­tion), Julia Höyng and Anto­nia van Dam (both Real Estate), Dr. Patric Mau (Intellec­tual Property), as well as Chris­tine Seiz and Sarah Liomin (both Commer­cial), Dr. Cars­ten Bormann and Mareike Heesing (both Foreign Invest­ment), Daniel Dohrn and Konstan­tin Ogil­vie (both anti­trust law). Holland & Knight advi­sed on U.S. legal matters, and Walker Morris advi­sed on U.K. legal matters. 

About Oppen­hoff

The Oppen­hoff team had previously advi­sed on the German aspects of the carve-out and acqui­si­tion of Avan­tor Inc.’s Clini­cal Services divi­sion. The resul­ting inde­pen­dent plat­form was subse­quently rena­med Reso­nant Clini­cal Solu­ti­ons. Oppen­hoff regu­larly advi­ses on add-on acqui­si­ti­ons of plat­forms in the private equity sector; most recently, among others, Schenk Tank­trans­port on its acqui­si­tion of Franz Fischer Spedi­tion, Rensa Filtra­tion on its acqui­si­tion of IREMA-Filter GmbH and its U.S. subsi­diary Aeolus Filter, and Stat­Lab Medi­cal Products on its acqui­si­tion of Histo­serve. — www.oppenhoff.eu